Renal function maintenance and protection agent, and method for evaluating effect thereof

Inventors: Masataka Kawarasaki (Tokyo, JP); Yosuke Chiba (Tokyo, JP); Akira Kamata (Tokyo, JP); Tomoaki Hashimoto (Tokyo, JP); Yoichiro Shirahama (Tokyo, JP)

Assignee: MARUHA NICHIRO CORPORATION

A61K31/202 A23K20/158 A23L33/12 A23L33/40 A61K9/0053 A61K9/0056 A61P13/12 G01N33/6812 A23V2002/00 G01N2800/52

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 12667551
App. No.: 17/254,256
Granted: Jun 30, 2026
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

Provided is a renal function maintenance and protection agent comprising as an active ingredient of a triglyceride of docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) or a mixture of a triglyceride of docosahexaenoic acid (DHA) and a triglyceride of eicosapentaenoic acid (EPA), which can be used as a pharmaceutical or food composition. A triglyceride of docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) or a mixture of a triglyceride of docosahexaenoic acid (DHA) and a triglyceride of eicosapentaenoic acid (EPA) is used as an active ingredient for renal function maintenance and protection agents.

Claims (2)

1 . A method of treating renal function deterioration due to hypertension, the method comprising administering to an administration target who is at risk of renal function deterioration a renal function maintenance and protective agent comprising a triglyceride of docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) itself or a mixture of a triglyceride of docosahexaenoic acid (DHA) and a triglyceride of eicosapentaenoic acid (EPA),

wherein the renal function maintenance and protective agent is formulated for oral administration.